A Cohort Study on Anti-microbial Stewardship in PICU
Starting soon
Conditions studied: Infections
In brief
Appropriate antimicrobial therapy is essential to ensuring positive patient outcomes. Inappropriate or suboptimal utilization of antibiotics can lead to increased length of stay, multidrug-resistant infections, and mortality. Critically ill intensive care patients are at risk of antibiotic failure and secondary infections associated with incorrect antibiotic use. Initiating effective therapy for infections based upon patients' risk factors, collection of appropriate cultures, daily evaluation of clinical status, and laboratory data, including antibiotic time outs, and shortened duration of therapy are ways to improve patients outcomes. Antimicrobial stewardship teams can assist ICU providers in managing and implementing these tactics. ICUs would benefit from employing empiric guidelines for antibiotic use, collecting appropriate specimens and implementing molecular diagnostics, optimizing the dosing of antibiotics, and reducing the duration of total therapy.
Key facts
- Study ID
- NCT05862688
- Run by
- Children's Hospital of Fudan University
- People needed
- 1000
- Starts
- 2026-07-01
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-02-17
Who can join
Age: 0 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients admitted to the ICU for more than 48 hour
You may not qualify if…
- Patients admitted to ICU less than 48 hours
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.